-
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective - ISPOR drug cost task force report - Part VI
-
Costs of Medication Non adherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature
-
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification
-
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report
-
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources - Task Force Report Part III
-
Good research practices for comparative effectiveness research - bias & confounding in the design - Task Force Report Part II
-
Good research practices for comparative effectiveness research – defining, reporting & interpreting - Task Force Report Part I
-
Multinational Trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data
-
Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures
-
Transferability of Economic Evaluations Across Jurisdictions - Good research practices task force report
-
Understanding Medication Compliance and Persistence from an Economics Perspective
-
Medication Compliance and Persistence: Terminology and Definitions
-
Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
-
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations
-
Principles of Good Practice for Budget Impact Analysis I
-
Using Real-World Data for Coverage and Payment Decisions
-
Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials
-
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures
-
Use of Pharmacoeconomics Information
-
A Checklist for Retrospective Database Studies
Questions?
For any questions about this report please contact us.